Da Volterra: Clinical Trials

6 trials sponsored by Da Volterra, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 2 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Not applicable1Completed 1

Follow Da Volterra: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)
DAV132 - Clostridium Difficile Infection
Not applicableCompletedDa Volterra2602018-10-312019-08-30
COMBACTE-CDI Understanding the Burden of C. Difficile Infection
No intervention - Clostridium Difficile Infection
CompletedUniversity of Leeds32402018-06-112022-02-09
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
no intervention - Clostridium Difficile
CompletedMJM Bonten10072016-09-272021-05-21
Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers
Moxifloxacin, DAV132, Negative control - Healthy Subjects
Phase 1CompletedDa Volterra1502016-05-112017-09-12
Safety and Efficacy Study of DAV132 in Healthy Volunteers
DAV132, Moxifloxacin, Negative Control - Healthy
Phase 1CompletedDa Volterra442014-03-012020-02-28
Multi-Antibiotic Resistance Carriage in Gut Flora
Intestinal Bacteria Flora Disturbance
CompletedDa Volterra2722012-03-012014-05-29

Conditions studied

Clostridium Infections (3)

Interventions

Moxifloxacin (2)

Countries

France (4)  ·  Germany (2)  ·  Romania (2)  ·  Bulgaria (1)  ·  Greece (1)  ·  Netherlands (1)  ·  Serbia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Marc Bonten, MD, PhD (1)  ·  Mark Wilcox, MD (1)  ·  Xavier Duval, MD (1)  ·  Yves Donazzolo (1)

Results publications

PMID 29186529, PMID 33854064, PMID 33854066, PMID 39535868